Cranial Neuralgias

2021 ◽  
Vol 27 (3) ◽  
pp. 665-685
Author(s):  
Carrie Robertson
Keyword(s):  
Cranial Neuralgias

Cranial neuralgias

2010 ◽  
pp. 663-678 ◽  
Author(s):  
G. Cruccu ◽  
L.H. Bonamico ◽  
J.M. Zakrzewska
Keyword(s):  
Cranial Neuralgias

scholarly journals Nervus intermedius and the surgical management of geniculate neuralgia

2019 ◽  
Vol 131 (2) ◽  
pp. 343-351 ◽  
Author(s):  
Maria Peris-Celda ◽  
Soliman Oushy ◽  
Avital Perry ◽  
Christopher S. Graffeo ◽  
Lucas P. Carlstrom ◽  
...  
Keyword(s):  
Pain Syndrome ◽  
Symptomatic Improvement ◽  
Sensory Innervation ◽  
Complex Nature ◽  
Simultaneous Treatment ◽  
Repeat Surgery ◽  
Pain Outcomes ◽  
Cranial Neuralgias ◽  
Almost All ◽  
Nervus Intermedius

OBJECTIVEGeniculate neuralgia (GN) is an uncommon craniofacial pain syndrome attributable to nervus intermedius (NI) dysfunction. Diagnosis and treatment can be challenging, due to the complex nature of ear sensory innervation, resulting in clinical overlap with trigeminal neuralgia (TN) and glossopharyngeal neuralgia (GPN).METHODSA retrospective review of a prospective neurosurgical database at our institution was performed, 2000–2017, with a corresponding systematic literature review. Pain outcomes were dichotomized as unfavorable for unchanged/worsened symptoms versus favorable if improved/resolved. Eight formalin-fixed brains were examined to describe NI at the brainstem.RESULTSEleven patients were surgically treated for GN—9 primary, 2 reoperations. The median age was 48, 7 patients were female, and the median follow-up was 11 months (range 3–143). Seven had ≥ 2 probable cranial neuralgias. NI was sectioned in 9 and treated via microvascular decompression (MVD) in 2. Five patients underwent simultaneous treatment for TN (4 MVD; 1 rhizotomy) and 5 for GPN (3 MVD; 2 rhizotomy). Eleven reported symptomatic improvement (100%); 8 initially reported complete resolution (73%). Pain outcomes at last contact were favorable in 8 (73%)—all among the 9 primary operations (89% vs 0%, p = 0.054). Six prior series reported outcomes in 111 patients.CONCLUSIONSGN is rare, and diagnosis is confounded by symptomatic overlap with TN/GPN. Directed treatment of all possible neuralgias improved pain control in almost all primary operations. Repeat surgery seems a risk factor for an unfavorable outcome. NI is adherent to superomedial VIII at the brainstem; the intermediate/cisternal portion is optimal for visualization and sectioning.

Cranial Neuralgias

Headache ◽  
2012 ◽  
pp. 243-264
Author(s):  
Mervyn J. Eadie
Keyword(s):  
Cranial Neuralgias

Nerve Block for the Treatment of Headaches and Cranial Neuralgias - A Practical Approach

2015 ◽  
Vol 55 ◽  
pp. 59-71 ◽  
Author(s):  
Fabíola Dach ◽  
Álan L. Éckeli ◽  
Karen dos S. Ferreira ◽  
José G. Speciali
Keyword(s):  
Nerve Block ◽  
Practical Approach ◽  
Cranial Neuralgias

scholarly journals Gabapentinoid prescription in Oral Medicine and Oral Surgery practice. Part II − a systematic scoping review of the literature

2020 ◽  
Vol 26 (4) ◽  
pp. 37
Author(s):  
Arek Sulukdjian ◽  
Richard L'Homme ◽  
Audrey Chanlon ◽  
Nathan Moreau
Keyword(s):  
Scoping Review ◽  
Postoperative Nausea ◽  
Orofacial Pain ◽  
Oral Surgery ◽  
Treatment Options ◽  
Pain Clinic ◽  
Oral Medicine ◽  
Grade Scale ◽  
Cranial Neuralgias

Introduction: Gabapentinoids, pregabalin and gabapentin, neuronal voltage-gated calcium channel inhibitors are first-line treatments for painful neuropathic conditions (and several non-neuropathic painful conditions). Nevertheless, their efficacy and prescription in Oral Medicine and Oral Surgery practice has received little attention so far. A previous article, the first of a two-part series, presented the experience of a French tertiary orofacial pain clinic regarding the prescription of gabapentinoids in orofacial conditions. This second article aimed to explore the scientific literature on the subject. Material and methods: A systematic scoping review was conducted on multiple relevant databases (MEDLINE®, Cochrane®, Agence Nationale de Sécurité du Médicament et des produits de santé, Haute Autorité de Santé) and journal archives (JOMOS, JSOMFS) to assess the indications, non-indications and contraindications of gabapentinoids in an Oral Medicine/Oral Surgery context. Results: Out of 131 records selected during the initial screening, 34 matched the inclusion criteria and were used for subsequent analyses. Gabapentinoids were prescribed in three clinical contexts: orofacial pain management (32 studies), anxiolysis (1 study) and prevention of postoperative nausea/vomiting (1 study), with variable quality of evidence: high (6 studies), moderate (3 studies), low (5 studies) and very low (20 studies) quality studies (GRADE scale). Untoward effects of gabapentinoids were reported in 16 studies, mainly neurological (vertigo, drowsiness, sedation) and gastro-intestinal (nausea, vomiting, diarrhea, constipation). Gabapentinoids were ineffective in preemptive and postoperative analgesia and for the management of mucositis-related pain. Discussion: There is some evidence supporting the use of gabapentinoids in Oral Medicine/Oral Surgery in adherence with current practices observed in France and other countries (practices often extrapolated from their use in other non-orofacial painful conditions). The methodological quality of the studies included in this scoping review is often poor and publication bias is most probable in this field. Therefore, any conclusion drawn from such studies must be subject to circumspection. Conclusion: Data obtained from the present scoping review suggests the potential use of gabapentinoids as second-line treatments for anxiolysis, prevention of postoperative nausea/vomiting and the management of trigeminal neuralgia and masticatory myalgia. Other potential indications of gabapentinoids in Oral Medicine/Oral Surgery practice include cranial neuralgias, post-traumatic trigeminal neuropathies, first bite syndrome, burning mouth syndrome and migraine prophylaxis, when other treatment options are inefficient or unavailable.

Sign in / Sign up

Export Citation Format

Share Document